V
VCYT
Veracyte
32.67
+0.52+1.62%After Hours: 32.50 -0.17 -0.52%16:47 04/08 EDT
OPEN/PREV CLOSE33.78/32.15
TODAY RANGE32.45-34.09
VOL826.01K
MARKET CAP2.60B
52 WEEK RANGE22.61-50.71
AVG VOL (3M)925.58K
% TURNOVER1.04%
TURNOVER--
P/E (TTM)39.67
% RANGE5.05%
EPS(TTM)0.8235
P/E(FORWARD)36.71
P/B1.980
BVPS16.50
DIVIDEND--
P/S5.01
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.57B
SHARES OUTSTANDING79.46M
NEXT EARNINGS05/05-05/11
FREE FLOAT78.61M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·2d ago
Cathie Wood's weekly moves signal shift to AI, precision medicine
Dow Jones·04/01 11:52
Veracyte Is Maintained at Buy by Needham
Dow Jones·04/01 11:52
Veracyte Price Target Maintained With a $48.00/Share by Needham
Benzinga·04/01 11:42
Needham Maintains Buy on Veracyte, Maintains $48 Price Target
Seeking Alpha·03/31 10:35
Cathie Wood's Ark Invest in broad sell-off; trims AI, crypto, internet names
Dow Jones·03/30 15:11
Veracyte Is Maintained at Buy by Guggenheim
Dow Jones·03/30 15:11
Veracyte Price Target Cut to $45.00/Share From $50.00 by Guggenheim
Benzinga·03/30 15:01
Guggenheim Maintains Buy on Veracyte, Lowers Price Target to $45
TipRanks·03/30 11:52
Veracyte price target lowered to $45 from $50 at Guggenheim
NASDAQ·03/27 15:30
Veracyte (VCYT) Down 15.4% Since Last Earnings Report: Can It Rebound?
TipRanks·03/16 20:57
Veracyte Appoints Kevin Haas as Chief Technology Leader
TipRanks·03/16 20:26
Veracyte names Kevin Haas as Chief Development and Technology Officer
Reuters·03/16 20:15
Veracyte appoints Kevin Haas as chief development and technology officer
Same Industry
Name/Symbol
Change%
Price